Login / Signup

Financial Conflicts of Interest in Propensity Score-Matched Studies Evaluating Biologics and Biosimilars for Inflammatory Bowel Disease.

Karam ElsolhDaniel ThamMichael A ScaffidiNikko GimpayaRishi BansalNazi TorabiJuana LiYash VermaRishad KhanSamir C Grover
Published in: Journal of the Canadian Association of Gastroenterology (2022)
Overall, we found a high burden of undisclosed conflicts among authors of PSM studies comparing IBD biologics and biosimilars. Given the importance of PSM studies as a means for biologic comparison and the potential for undue industry influence from these payments, authors should ensure greater transparency with reporting of industry relationships.
Keyphrases
  • case control
  • emergency department
  • climate change
  • drug induced